CLL/MCL

Videos

Triplet Therapy Yields High Response Rates, MRD Undetectability in Patients with MCL

07/08/2021

Tycel Phillips, MD, discusses the use of venetoclax, lenalidomode, and rituximab in patients with newly diagnosed MCL. These data were presented at the 2021 ASCO Annual Meeting.

Tycel Phillips, MD, discusses...

07/08/2021

Oncology

Videos

Peter Riedell, MD, Talks Impact of Time to Relapse After AutoHCT in MCL

07/02/2021

Peter Riedell, MD, discusses the impact of time to relapse on OS in patients with MCL following front-line high-dose therapy and autoHTC.

Peter Riedell, MD, discusses the...

07/02/2021

Oncology

Podcasts

Improvements in the Treatment of Patients With MCL Over the Past Decade

06/07/2021

Peter Martin, MD, discusses various treatment patterns and outcomes of patients with MCL over the past 10 years; these data were presented at the 2021 ASCO Annual Meeting.

Peter Martin, MD, discusses...

06/07/2021

Oncology

Conference Insider

Important to Control for FN Risks During Comparative Effectiveness Analyses of Breast Cancer, NHL

03/19/2021

Patients with NHL with intermediate risk for FN maintain that risk even with pegfilgrastim prophylaxis, according to research presented at the NCCN Annual Conference.

Patients with NHL with...

03/19/2021

Oncology

Conference Insider

Comorbidities in Older Patients With Lymphoma Have Well-Defined Patterns

03/19/2021

Study findings have led experts to suggest that comorbidities in patients with non-Hodgkin’s lymphoma do not present randomly, but have distinct patterns, according to research presented at the NCCN 2021 Virtual Annual Conference.

Study findings have led experts...

03/19/2021

Oncology

Conference Insider

ctDNA Could Improve Monitoring of Response to Chemo in ALL

03/18/2021

The current protocol for monitoring the response to chemo in patients with ALL is a bone marrow biopsy, but a better one may exist, according to data presented at the NCCN Annual Conference.

The current protocol for...

03/18/2021

Oncology

Conference Insider

Experts Estimate Prevalence of Future FL, DLBCL Cases in the United States, Europe

03/18/2021

Study findings lead experts to suggest that the prevalence of DLBCL and FL will likely rise in the United States and Europe, according to research presented at the NCCN Annual Conference.

Study findings lead experts to...

03/18/2021

Oncology